Pregestational Diabetes and Congenital Heart Defects

Area of Science:

• Cardiology
• Developmental Biology
• Endocrinology

Background:

• Maternal diabetes, both pregestational and gestational, is linked to a higher incidence of congenital heart defects (CHDs) in newborns.
• Pregestational diabetes poses a greater risk for cardiac malformations compared to gestational diabetes.
• All phenotypes of CHDs appear to be more prevalent in pregnancies affected by maternal diabetes.

Approach:

• This review synthesizes current research on the mechanisms linking maternal diabetes to fetal cardiac development.
• It explores how maternal diabetes influences the formation of the fetal heart.
• The review discusses ongoing therapeutic strategies aimed at mitigating these risks.

Key Points:

• Consistent evidence demonstrates a significant increase in CHD risk with maternal diabetes.
• Pregestational diabetes is particularly associated with more severe cardiac malformations.
• Existing therapies to reduce risks in diabetic pregnancies require further validation.

Conclusions:

• Further investigation is needed to fully elucidate the complex mechanisms underlying diabetes-induced CHDs.
• Understanding these pathways is crucial for developing targeted interventions.
• Improving outcomes for infants born to diabetic mothers remains a critical research objective.